Accelerate Diagnostics, Inc. (AXDX) Financial Statements (2024 and earlier)

Company Profile

Business Address 3950 S. COUNTRY CLUB ROAD #470
TUCSON, AZ 85714
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:45,60040,69836,18161,01466,26028,513
Cash and cash equivalents34,90539,89835,78161,01466,26028,513
Short-term investments900800400   
Other undisclosed cash, cash equivalents, and short-term investments9,795     
Receivables2,4162,3201,5503,2221,8601,946
Inventory, net of allowances, customer advances and progress billings5,1945,0679,2168,0597,7468,063
Inventory5,1945,0679,2168,0597,7468,063
Prepaid expense8187681,172955980 
Other current assets2,0251,5581,7801,165576468
Other undisclosed current assets(39)22,92032,08847,437100,21881,498
Total current assets:56,01473,33181,987121,852177,640120,488
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization2,422   
Operating lease, right-of-use asset1,8592,5103,1833,917
Property, plant and equipment3,4785,3896,1357,9057,3034,890
Intangible assets, net (including goodwill)     114134
Intangible assets, net (excluding goodwill)     114134
Other noncurrent assets1,2421,8172,120750208 
Total noncurrent assets:9,0019,71611,43812,5727,6255,024
TOTAL ASSETS:65,01583,04793,425134,424185,265125,512
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7,1835,7455,5437,4417,5463,636
Interest and dividends payable9091,2621,2621,262 
Accounts payable4,5011,9831,2902,3511,3222,080
Accrued liabilities2,6822,8532,9913,8284,962 
Other undisclosed accounts payable and accrued liabilities      1,556
Deferred revenue547451376271
Debt57,52680553450  
Derivative instruments and hedges, liabilities      
Contract with customer, liability217
Other undisclosed current liabilities1,301669497  3,151
Total current liabilities:66,5576,9456,9698,1627,7636,787
Noncurrent Liabilities
Long-term debt and lease obligation782110,3657,722133,622120,074 
Long-term debt, excluding current maturities 107,9844,659130,043120,074 
Finance lease, liability782   
Liabilities, other than long-term debt19,277808335195321
Deferred revenue    
Due to related parties16,858     
Other liabilities874808335195321
Operating lease, liability1,5452,3813,0633,579
Other undisclosed noncurrent liabilities 663 141,211   
Total noncurrent liabilities:20,722111,173149,268133,641120,12721
Total liabilities:87,279118,118156,237141,803127,8906,808
Equity
Equity, attributable to parent, including:(22,264)(35,071)(62,812)(7,379)57,375118,704
Preferred stock 44    
Common stock      
Treasury stock, value(45,067)(45,067)(45,067)(45,067)(45,067) 
Additional paid in capital630,341580,652475,072452,344432,885360,620
Accumulated other comprehensive income (loss)(400)(60)91(58)(149) 
Accumulated deficit(607,239)(570,668)(492,966)(414,653)(330,348)(241,972)
Other undisclosed equity, attributable to parent 976858555456
Total equity:(22,264)(35,071)(62,812)(7,379)57,375118,704
TOTAL LIABILITIES AND EQUITY:65,01583,04793,425134,424185,265125,512

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues12,75211,78211,1659,2975,6704,177
Revenue, net4,177
Cost of revenue
(Cost of Goods and Services Sold)
(9,449)(12,163)(6,706)(4,897)(3,187)(1,002)
Gross profit:3,303(381)4,4594,4002,4833,175
Operating expenses(66,108)(71,179)(68,159)(77,231)(82,852)(67,359)
Operating loss:(62,805)(71,560)(63,700)(72,831)(80,369)(64,184)
Nonoperating income (expense)235(6,097)(14,602)(11,158)(7,125)323
Investment income, nonoperating  (99)427621(326)
Other nonoperating income (expense)235(6,097)(14,503)(11,585)(7,746)649
Interest and debt expense(2,268)9,793(15,457)(600)(399) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   15,556173(222)326
Loss from continuing operations before equity method investments, income taxes:(64,838)(67,864)(78,203)(84,416)(88,115)(63,535)
Other undisclosed income (loss) from continuing operations before income taxes2,268(9,793)    
Loss from continuing operations before income taxes:(62,570)(77,657)(78,203)(84,416)(88,115)(63,535)
Income tax expense (benefit)77(45)(5)111(211)(493)
Other undisclosed income from continuing operations      
Loss from continuing operations:(62,493)(77,702)(78,208)(84,305)(88,326)(64,028)
Loss before gain (loss) on sale of properties:(77,702)(78,208)(84,305)(88,326)(64,028)
Net loss available to common stockholders, diluted:(62,493)(77,702)(78,208)(84,305)(88,326)(64,028)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(62,493)(77,702)(78,208)(84,305)(88,326)(64,028)
Comprehensive loss:(62,493)(77,702)(78,208)(84,305)(88,326)(64,028)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(340)(151)14991(149)204
Comprehensive loss, net of tax, attributable to parent:(62,833)(77,853)(78,059)(84,214)(88,475)(63,824)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: